ResMed Shares Outstanding 2006-2018 | RMD

ResMed shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • ResMed shares outstanding for the quarter ending September 30, 2018 were 0.144B, a 0.38% increase year-over-year.
  • ResMed 2018 shares outstanding were 0.144B, a 1.08% increase from 2017.
  • ResMed 2017 shares outstanding were 0.142B, a 0.55% increase from 2016.
  • ResMed 2016 shares outstanding were 0.142B, a 0.71% decline from 2015.
ResMed Annual Shares Outstanding
(Millions of Shares)
2018 144
2017 142
2016 142
2015 143
2014 144
2013 146
2012 149
2011 157
2010 155
2009 154
2008 157
2007 157
2006 154
2005 150
ResMed Quarterly Shares Outstanding
(Millions of Shares)
Q1 2018 144
Q4 2018 144
Q3 2018 144
Q2 2017 144
Q1 2017 143
Q4 2017 142
Q3 2017 143
Q2 2016 142
Q1 2016 142
Q4 2016 142
Q3 2016 141
Q2 2015 141
Q1 2015 142
Q4 2015 143
Q3 2015 143
Q2 2014 142
Q1 2014 143
Q4 2014 144
Q3 2014 143
Q2 2013 145
Q1 2013 145
Q4 2013 146
Q3 2013 147
Q2 2012 147
Q1 2012 146
Q4 2012 149
Q3 2012 147
Q2 2011 150
Q1 2011 154
Q4 2011 157
Q3 2011 158
Q2 2010 158
Q1 2010 157
Q4 2010 155
Q3 2010 156
Q2 2009 154
Q1 2009 154
Q4 2009 154
Q3 2009 155
Q2 2008 155
Q1 2008 154
Q4 2008 157
Q3 2008 157
Q2 2007 157
Q1 2007 158
Q4 2007 157
Q3 2007 154
Q2 2006 156
Q1 2006 156
Q4 2006 154
Q3 2006 155
Q2 2005 154
Q1 2005 153
Q4 2005 150
Q3 2005 151
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.846B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Stryker (SYK) United States $64.420B 24.28
Boston Scientific (BSX) United States $51.491B 26.02
Baxter (BAX) United States $35.393B 22.86
Zimmer Biomet Holdings (ZBH) United States $23.875B 15.48
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
Perrigo (PRGO) Ireland $8.596B 13.05
Bio-Rad Laboratories (BIO) United States $8.274B 52.91
Canopy Growth (CGC) Canada $8.174B 0.00
Hill-Rom Holdings (HRC) United States $6.270B 19.88
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
AtriCure (ATRC) United States $1.241B 0.00
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Meridian Bioscience (VIVO) United States $0.823B 26.23
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.756B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.34
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Fonar (FONR) United States $0.141B 7.06
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 21.07
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00